Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Decreased level of endogenous secretory receptor for advanced glycation end-products in diabetes with concomitant hyperlipidemia

Z. Turk, S. Ljubić, J. Boras

. 2014 ; 63 (2) : 199-205.

Language English Country Czech Republic

Document type Journal Article, Research Support, Non-U.S. Gov't

Persistent link   https://www.medvik.cz/link/bmc15003897

Endogenous secretory receptor (esRAGE) for advanced glycation end-product (AGE) acts as decoy for AGEs. The AGE-to-esRAGE ratio was hypothesized to be implicated in diabetic vasculopathy. We investigated an association of esRAGE and methylglyoxal-adducts serum level, as well as AGE-to-esRAGE ratio in subpopulation of diabetic patients with or without concomitant hyperlipidemia and macrovascular disease in history. In diabetes with concomitant hyperlipidemia esRAGE was significantly decreased compared to hyperlipidemia with normal glucose metabolism (0.306+/-0.2 vs. 0.367+/-0.1; p=0.019) or diabetes alone (0.306+/-0.2 vs. 0.404+/-0.1; p=0.004). High AGE/esRAGE ratio, found in diabetic patients with hyperlipidemia, pointed to increased production of AGEs and low expression of esRAGE. In multivariable analysis adjusted for several confounding factors, increased AGE/esRAGE ratio was recognized as a high risk for vascular disease outcomes.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc15003897
003      
CZ-PrNML
005      
20150129121314.0
007      
ta
008      
150128s2014 xr d f 000 0|eng||
009      
AR
024    7_
$a 10.33549/physiolres.932559 $2 doi
035    __
$a (PubMed)24397807
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Turk, Z $u Department of Laboratory Medicine, Vuk Vrhovac Clinic, KB Merkur, Zagreb, Croatia
245    10
$a Decreased level of endogenous secretory receptor for advanced glycation end-products in diabetes with concomitant hyperlipidemia / $c Z. Turk, S. Ljubić, J. Boras
520    9_
$a Endogenous secretory receptor (esRAGE) for advanced glycation end-product (AGE) acts as decoy for AGEs. The AGE-to-esRAGE ratio was hypothesized to be implicated in diabetic vasculopathy. We investigated an association of esRAGE and methylglyoxal-adducts serum level, as well as AGE-to-esRAGE ratio in subpopulation of diabetic patients with or without concomitant hyperlipidemia and macrovascular disease in history. In diabetes with concomitant hyperlipidemia esRAGE was significantly decreased compared to hyperlipidemia with normal glucose metabolism (0.306+/-0.2 vs. 0.367+/-0.1; p=0.019) or diabetes alone (0.306+/-0.2 vs. 0.404+/-0.1; p=0.004). High AGE/esRAGE ratio, found in diabetic patients with hyperlipidemia, pointed to increased production of AGEs and low expression of esRAGE. In multivariable analysis adjusted for several confounding factors, increased AGE/esRAGE ratio was recognized as a high risk for vascular disease outcomes.
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a biologické markery $x krev $7 D015415
650    _2
$a diabetes mellitus 2. typu $x krev $x diagnóza $x epidemiologie $7 D003924
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a produkty pokročilé glykace $x krev $7 D017127
650    _2
$a lidé $7 D006801
650    _2
$a hyperlipidemie $x krev $x epidemiologie $7 D006949
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a receptory imunologické $x krev $7 D011971
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Ljubić, S $u Department of Medicine, Vuk Vrhovac Clinic, KB Merkur, Zagreb, Croatia
700    1_
$a Boras, J $u Department of Medicine, Vuk Vrhovac Clinic, KB Merkur, Zagreb, Croatia
773    0_
$w MED00003824 $t Physiological research $x 1802-9973 $g Roč. 63, č. 2 (2014), s. 199-205
856    41
$u http://www.biomed.cas.cz/physiolres/ $y domovská stránka časopisu
910    __
$a ABA008 $b A 4120 $c 266 $y 4 $z 0
990    __
$a 20150128 $b ABA008
991    __
$a 20150129121509 $b ABA008
999    __
$a ok $b bmc $g 1060957 $s 886652
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2014 $b 63 $c 2 $d 199-205 $i 1802-9973 $m Physiological research $n Physiol. Res. (Print) $x MED00003824
LZP    __
$b NLK118 $a Pubmed-20150128

Find record

Citation metrics

Archiving options